Accompanied by induction of apoptosis, PTL and ATO evoke autophagic activity by inhibiting PI3K/Akt/mTOR pathway, and consciously controlling of autophagy can accelerate the anti-HCC efficacy of combination of PTL and ATO. Here, MTOR is linked to hepatocellular carcinoma.